Skip to main content
CSBR logo

Champions Oncology, Inc.

CSBRNASDAQHealthcareBiotechnology

$4.86Today:- (-)1Y −29.48%

As of Oct 26, 2026 close

Market cap
$67.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$4.59$8.31
Volume (live)
-
Avg. volume (3M)
11.06K

Champions Oncology (CSBR) Cash Flow Statement

In fiscal 2026 (fiscal year ended Apr 30, 2026), Champions Oncology used $4.47M of cash in operating activities and spent $564.00K on capital expenditures. That left free cash flow of −$5.04M.

Champions Oncology Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Champions Oncology, Inc. (CSBR) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
Operating Activities
Net Income-1.184.70-7.28-5.340.550.36-1.980.13-1.51-6.88
Depreciation & Amortization1.381.641.872.251.631.180.830.610.360.17
Deferred Income Tax0.00-0.180.000.000.000.050.560.07-0.040.02
Stock Based Compensation1.240.651.120.860.910.600.600.641.002.66
Change in Working Capital-7.42-0.62-3.824.242.34-4.202.490.01-1.531.15
Change in Accounts Receivable-2.00-1.44-1.991.31-2.82-2.27-0.67-0.53-1.60-0.99
Change in Inventory0.000.000.000.000.00-1.101.040.57-0.030.40
Change in Accounts Payable2.56-1.750.472.470.97-1.250.330.650.30-0.04
Change in Other Working Capital1.37-1.18-1.51-1.090.79-0.812.95-0.68-0.212.18
Other Operating Activities1.371.011.981.950.790.370.400.410.490.04
Net Cash from Operating Activities-4.477.39-6.143.976.50-1.682.911.86-1.23-2.84
Investing Activities
Capital Expenditures-0.56-0.39-0.84-2.87-2.38-3.28-2.22-0.83-1.23-0.77
Acquisitions0.020.000.000.000.000.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.110.000.000.000.00
Net Cash from Investing Activities-0.54-0.39-0.84-2.87-2.38-3.17-2.22-0.83-1.23-0.77
Financing Activities
Debt Repayment-0.14-0.15-0.150.000.00-0.17-0.04-0.26-0.03-0.02
Common Stock Issued0.230.320.250.090.211.374.461.470.044.34
Common Stock Repurchased0.000.00-0.63-0.070.000.000.000.000.000.00
Net Cash from Financing Activities0.100.17-0.530.010.211.204.421.200.014.32
Summary
Effect of Forex Changes on Cash0.000.000.000.020.000.000.000.000.000.00
Net Change in Cash-4.917.17-7.501.114.32-3.665.112.23-2.440.71
Cash at Beginning of Period9.792.6210.129.014.698.343.241.013.302.59
Cash at End of Period4.879.792.6210.109.014.698.343.240.863.30
Free Cash Flow-5.047.00-6.971.104.11-4.960.691.03-2.46-3.61

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Champions Oncology Cash Flow

What is Champions Oncology's free cash flow?

Champions Oncology had negative free cash flow of $5.04M in fiscal 2026 (fiscal year ended Apr 30, 2026), operating cash flow of −$4.47M minus $564.00K of capital expenditures.

How much does Champions Oncology spend on capital expenditures?

Champions Oncology spent $564.00K on capital expenditures in fiscal 2026, compared with $389.00K a year earlier.

Does Champions Oncology pay dividends or buy back shares?

Champions Oncology's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition